Chemoprevention of breast cancer
Kinsinger L, Harris R, Lewis C, Wooddell M
 
 
Record Status

This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database.

Citation
Kinsinger L, Harris R, Lewis C, Wooddell M. Chemoprevention of breast cancer. Rockville: Agency for Healthcare Research and Quality (AHRQ). Preventive Services Task Force Systematic Evidence Review 8. 2002
Authors' objectives

This review aims to examine the evidence about the benefits and harms of breast cancer chemoprevention for pre- and postmenopausal women.

Authors' conclusions

Tamoxifen and raloxifene reduce the incidence of breast cancer in women over a wide range of ages and levels of breast cancer risk. Both drugs may also have other benefits, but they may cause harm in otherwise healthy women who take them for prophylaxis.

Project page URL
http://www.ahrq.gov/clinic/uspstf/uspsbrpv.htm
Indexing Status
Subject indexing assigned by CRD
MeSH
Breast Neoplasms /drug therapy; Chemoprevention; Drug Therapy
Language Published
English
Country of organisation
United States
Address for correspondence
Center for Outcomes and Evidence Technology Assessment Program, 540 Gaither Road, Rockville, MD 20850, USA. Tel: +1 301 427 1610; Fax: +1 301 427 1639; Email: martin.erlichman@ahrq.hhs.gov
AccessionNumber
32003001085
Date bibliographic record published
30/09/2003
Date abstract record published
30/09/2003
 
Health Technology Assessment (HTA) database
Copyright © 2025 Agency for Healthcare Research and Quality (AHRQ)
 
Homepage
Options
Print
PDF
 
PubMed record
Original research
 
Share
 

Message for HTA database users